Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Geron Corporation (GERN) vs Solid Biosciences Inc. (SLDB)

Geron Corporation and Solid Biosciences Inc. are both Biotechnology companies. Geron Corporation and Solid Biosciences Inc. are of similar size ($815.9M and $802.0M). Solid Biosciences Inc. has the higher net margin (0.00% vs −33.1%) and the higher return on invested capital (0.00% vs −89.9%). Across the 16 metrics below, Geron Corporation leads on 8 and Solid Biosciences Inc. on 8.

Valuation

Metric GERN SLDB Biotechnology median
P/E n/m n/m 7.88
P/S 4.13 93.13 11.47
P/B 3.87 2.80 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.59 59.52 10.73
Earnings yield (8.37%) (26.20%) (28.84%)
Free cash flow yield (13.58%) (17.92%) (23.03%)

Profitability

Metric GERN SLDB Biotechnology median
Gross margin 93.51% 0.00% 65.16%
Operating margin (25.31%) 0.00% 0.00%
Net margin (33.05%) 0.00% 0.00%
Free cash flow margin (56.10%) 0.00% 0.00%
Return on equity (28.28%) (65.50%) (57.72%)
Return on assets (12.59%) (56.83%) (49.22%)
Return on invested capital (89.85%) 0.00% 0.00%

Growth

Metric GERN SLDB Biotechnology median
Revenue growth (TTM) 24.39% — 5.64%
EPS growth (last fiscal year) 51.85% 34.97% —
Revenue growth, 5-year CAGR 273.49% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GERN SLDB Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 6.92 13.82 4.73
Net debt to EBITDA 3.28 1.05 0.96

Dividend

Metric GERN SLDB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GERN SLDB Biotechnology median
Market cap 815.94m 802.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack